About Imran Masood
Mr Imran Masood is a Consultant Ophthalmic Surgeon and Director of the Glaucoma service at the prestigious Birmingham and Midland Eye Centre (a tertiary referral centre). He deals with the full range of general ophthalmic conditions He has a subspecialist interest in the assessment, diagnosis and medical and surgical management of all forms of Glaucoma.
He holds the fellowship of the Royal College of Ophthalmologists and has undergone training in the management of routine and complex eye diseases at the world renowned Moorfields Eye Hospital in London.
Mr Imran Masood has a particular interest in angle closure glaucoma, complex cataract surgery, cataract surgery in glaucoma patients, complex trabeculectomy, aqueous shunt procedures and in minimally invasive (key hole) glaucoma operations. He is a national leader in MIGS (minimally invasive glaucoma surgery), he is the first surgeon in the UK to use the Hydrus Schlemm’s canal aqueous implant and is currently conducting a clinical trial of this device. He was one of the first surgeons in the UK to use the revolutionary Istent device and has the largest series in the UK of I-stent procedures in complex glaucoma patients (NHS and Private Patients). He has successfully treated a number of patients with complex glaucoma and cataract with these new and safe techniques.
Mr Imran Masood is continually involved in the development and refinement of these new techniques at the Birmingham and Midland Eye Centre.
His research interests include angle closure glaucoma, retinal vascular physiology in glaucoma, circadian rhythms in glaucoma patients and glaucoma surgery.
He is able to offer super-specialist opinions for glaucoma and cataract problems. (As a specialist in a national centre he receives referrals from other Consultants for glaucoma and complex cataract problems).
Mr Masood’s surgical complication rates are well below the national average. This is despite his very complex practice. He prides himself in the provision of a very high quality service to all patients.